Featured biodefense stocks
Aethlon Medical, Inc. (OTCBB:AEMD) Aethlon Medical creates targeted therapeutic devices to address infectious disease, cancer and neurodegenerative disorders. The company's lead product is the Aethlon Hemopurifier®, a first-in-class device that selectively targets the rapid elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. Exosome Sciences, Inc. is a majority owned subsidiary that is advancing exosome-based products to diagnose and monitor cancer, infectious disease and neurological disorders. www.aethlonmedical.com
Featured biodefense product
Aethlon Medical, Inc. - Aethlon Hemopurifier®
Defense and Security News
Research and Markets ; Face and Voice Biometrics - Global Strategic Business Report 2015: 3D Face Recognition Technology Takes Surveillance a Step Further
Dublin - March 26, 2015 (www.investorideas.com newswire) Research and Markets has announced the addition of the "Face and Voice Biometrics - Global Strategic Business Report" report to their offering.
ABI Research; Smartphones Fuel Biometrics in the Consumer and Enterprise Sector to US$3.1 Billion
London - March 25, 2015 (www.investorideas.com newswire) ABI Research forecasts US$3.1 billion global revenues in 2015 for biometrics in the consumer and enterprise sectors with much of the growth coming from smartphone solutions.
Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers
BOSTON, MA - March 24, 2015 (Investorideas.com Newswire) SoundView Technology Group issues a new research update following the recent shipment of NXT-ID's ( NASDAQ: NXTD; NXTDW ) Wocket smart wallet.
SoundView Research Update; Real-World Usage and Feedback of NXT-ID's (Nasdaq:NXTD; NXTDW) Wocket Smart Wallet at CVS, Whole Foods and Other Retailers
BOSTON, MA - March 24, 2015 (Investorideas.com Newswire) SoundView Technology Group issues a new research update following the recent shipment of NXT-ID's ( NASDAQ: NXTD; NXTDW ) Wocket smart wallet. SoundView was one of the selected user groups to provide real- orld user feedback on their experience with the Wocket in multiple scenarios and outlets.
Breaking Tech News: NXT-ID's (Nasdaq:NXTD; NXTDW) Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign
OXFORD, CT - March 23, 2015 (Investorideas.com Newswire) NXT-ID, Inc. ( NASDAQ: NXTD; NXTDW ), a biometric authentication company focused on the growing mobile commerce market, announces its biometric payment technology, the Wocket smart wallet, will start a new advertising campaign on CNBC television starting March 30th.
Breaking Tech News: NXT-ID's (Nasdaq:NXTD; NXTDW) Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special
OXFORD, CT - March 20, 2015 (Investorideas.com Newswire) NXT-ID, Inc. ( NASDAQ: NXTD; NXTDW ), a biometric authentication company focused on the growing mobile commerce market, announces its biometric payment technology, the Wocket smart wallet is one of the products featured in 2015 "I Want That" International CES Special, airing today, March 20th at 11:00 PM EST on the DIY Network.
Breaking Tech News: NXT-ID's (Nasdaq:NXTD; NXTDW) Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing"
OXFORD, CT - March 19, 2015 (Investorideas.com Newswire) NXT-ID, Inc. ( NASDAQ: NXTD ), a biometric authentication company focused on the growing mobile commerce market, announces its biometric payment technology, the Wocket smart wallet was featured in a news clip that aired this week on Washington DC's Fox 5 News.
NXT-ID (NXTD) Tech Media Alert: Fox 5 News' "The Next Great Thing" Shares Wocket as 'The Next Great Thing in Payments'
OXFORD, CT - March 17, 2015 (Investorideas.com Newswire) Investorideas.com, a global investor news site that covers tech stocks reports that NXT-ID, Inc.'s ( NASDAQ: NXTD ) (NXTDW) Wocket smart wallet was featured last night on Washington DC's Fox 5 News.
Breaking Tech News: Biometric Company NXT-ID (Nasdaq:NXTD; NXTDW) Ships Wocket Smart Wallets to Early Access Pre-Order Customers
OXFORD, CT - March 17, 2015 (Investorideas.com Newswire) NXT-ID, Inc. ( NASDAQ: NXTD ), a biometric authentication company focused on the growing mobile commerce market, announces it has shipped the first Wocket smart wallets.
Breaking Tech News: NXT-ID (Nasdaq:NXTD; NXTDW) Announces First Shipment of Wocket Smart Wallets to Early Access Pre-Order Customers
OXFORD, CT - March 16, 2015 (Investorideas.com Newswire) NXT-ID, Inc. ( NASDAQ: NXTD ), a biometric authentication company focused on the growing mobile commerce market, announces it has shipped Wocket smart wallets today.
Subscribe to Defense and Security News RSS
Biodefense Stock and Industry News from Google News
Fri, 27 Mar 2015 06:55:10 GMT
Biodefense Stocks Directory Preview
Aeolus Pharmaceuticals, Inc ( OTC:AOLS ) is developing a platform of a new class of broad-spectrum, catalytic-antioxidant compounds that protect healthy tissue from the damaging effects of radiation. Its first compound, AEOL 10150, is being developed for oncology indications, where it is used in combination with radiation therapy. It is also being developed, with funding by the US Department of Health and Human Services, as a medical countermeasure against chemical and radiological weapons, where its initial target indications are as a protective agent against the effects of acute radiation syndrome and delayed effects of acute radiation exposure. Aeolus' strategy is to leverage the substantial investment in toxicology, manufacturing, and preclinical and clinical studies made by US Government agencies in AEOL 10150, including the contract with BARDA valued, with options, at up to $118.4 million, to efficiently develop the compound for use in oncology.
Aethlon Medical, Inc. ( OTCBB: AEMD ) Aethlon Medical creates innovative medical devices to address life-threatening diseases. The Aethlon ADAPT™ (Adaptive Dialysis-like Affinity Platform Technology) establishes the basis for a new class of therapeutics that target the rapid elimination of disease enabling particles from the circulatory system of treated patients. The lead Aethlon ADAPT™ product is the Hemopurifier®, a device that addresses a broad-spectrum of viral pathogens as well as tumor-secreted exosomes that suppress the immune system of cancer patients. Aethlon is also operating under two government contracts with the Defense Advanced Research Projects Agency (DARPA) related the development of a medical device to reduce the incidence of sepsis. Exosome Sciences, Inc. is a majority owned Aethlon subsidiary that is advancing exosome-based strategies to diagnose and monitor cancer and infectious disease progression.
Alexium International Group ( ASX:AJX.AX ) is engaged in developing and licensing its intellectual property, Reactive Surface Treatment (RST) technology. Alexium is focused on developing the RST technology for a range of military and commercial applications. Alexium’s Reactive Surface Treatment (RST) is a technology for nanoscopic coatings that combines advanced materials chemistry with a processing step. Alexium’s Reactive Surface Treatment (RST) uses cold microwave energy to direct a precursor’s polymerization onto a substrate’s surface. Its technology is used in textiles, air/fluid filtration, industrial coatings, composite fibers, leather, glass/lens surface treatment, bulk chemicals and thin films. BIODEFENSE: Responding to specific military and first responder needs, Alexium developed the Cleanshell® chemistry to offer a new generation of liquid repellency protection in chemical and biological threat scenarios. Cleanshell® CB is an advanced repellency treatment, optimized for chemical and biological protection. Cleanshell® CB has been optimized to provide excellent water and oil repellency, but has also dramatically increased the repellency of Chemical Warfare Agent (CWA) simulants. Cleanshell® CB offers days of protection versus minutes for conventional fluorocarbon repellency finishes.
American Science and Engineering, Inc ( NasdaqGS: ASEI ) is a leading worldwide supplier of innovative X-ray inspection systems. With over 50 years of experience in developing advanced X-ray security systems, the Company's product line utilizes a combination of technologies, including patented Z Backscatter™ technology, Radioactive Threat Detection (RTD), high energy transmission and dual energy transmission X-ray. These technologies offer superior X-ray threat detection for plastic explosives, plastic weapons, liquid explosives, dirty bombs and nuclear devices. AS&E's complete range of products include cargo inspection systems for port and border security baggage screening systems for facility and aviation security, and personnel and passenger screening systems. AS&E® systems protect high-threat facilities and help combat terrorism, trade fraud, drug smuggling, weapon smuggling, illegal immigration, and people smuggling.
BRUKER Corporation ( NasdaqGS: BRKR ) is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial, diagnostics and applied analysis. CBRN (Chemical, biological, radiological, and nuclear defense) : The CBRNE threats facing Armed Forces, Emergency and Security Services across the globe are complex. Simple and reliable solutions are required in order to provide protection and fast, effective response. As the market leader in CBRNE for over 20 years, Bruker understand the threat and needs of those operating against it. Our trusted equipment and software is installed around the world providing unrivalled protection. Our equipment is always easy to use and enables full spectrum Detection, Identification and Monitoring utilising state of the art technology.
Cepheid ( NasdaqGS: CPHD ) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the Company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the Company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. BIOTHREATS : The Cepheid GeneXpert® System makes biothreat agent detection possible in minutes -- all from unprepared samples. This easy-to-use, automated and highly accurate real-time PCR instrument combines the ingenuity of more than 30 patents into a sophisticated genetic tool for first responders. A patented, disposable, cartridge test for anthrax is available now, and can be performed on-site -- delivering critical answers in critical situations.
View the full Biodefense Stocks directory
View the full Homeland Defense/ Defense Stocks directory as a member or in pdf
Defense stocks Indices and ETF's
- PHLX DEFENSE SECTOR INDEX (Philadelphia: ^DFX)
- S&P Sector Indices Brochure
- Standard and Poor's 500 Aerospace & Defense Index is a capitalization-weighted index. The index was developed with a base level of 10 for the 1941-43 base period. This is a GICS level 4 sub-industry group. The parent index is SPX. This is a GICS Level 4 Sub-Industry group.
- The Amex Defense Index (DFI) is an equal dollar weighted Index designed to represent a cross section of widely held, highly capitalized companies involved in providing systems, equipment and services to the United States government and its allies for the purpose of supporting military, defense and intelligence efforts. The component stocks operate in industry segments that include, but are not limited to, military aircraft manufacturing, shipbuilding, ground transportation, aerospace instrumentation and technology, specialized communication and radar systems, ammunition and weapon systems.
- The iShares Dow Jones U.S. Aerospace & Defense Index Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Dow Jones U.S. Select Aerospace & Defense Index.
- The SPADE Defense Index (AMEX: DXS) is a modified market cap-weighted index that was developed to provide a financial benchmark for the performance of companies involved with the defense, homeland security, and space. More than 50 companies currently comprise the index. Information on the Index -- including its methodology, rules, constituents, and performance -- can be found at http://www.spadeindex.com. In October 2005, the first (and currently only) exchange traded fund on defense and homeland security was launched by Powershares. The Powershares Aerospace & Defense Portfolio ETF trades under the symbol 'PPA' and is designed to track the performance of the SPADE. - more info